1 terminated, 1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Desmoglein 3: new trials by email Literature Review of Desmoglein 3 trials Research Report on Desmoglein 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Middle Meningeal Artery Embolization for Chronic Subdural Hematoma Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA), Drainage of Subdural Hematoma - Chronic Subdural Hematoma | Withdrawn | Washington University School of Medicine | 2019-09-19 | 2025-07-22 | ||
| HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer HepaSphere/QuadraSphere Microspheres, PVA, lipiodol, doxorubicin - Hepatocellular Carcinoma | Phase 3 | Terminated | Merit Medical Systems, Inc. | 235 | 2011-06-01 | 2021-11-30 |
Carcinoma, Hepatocellular (1) · Hematoma, Subdural, Chronic (1)
Merit Medical Systems, Inc. (1) · Washington University School of Medicine (1)
United States (2) · Belgium (1) · France (1) · Greece (1) · Italy (1)
Josep Llovet, MD (1) · Joshua W Osbun, MD (1) · Michael Soulen, MD (1) · Riccardo Lencioni, MD (1)